A better understanding of the complex and potentially opposing functions of MLKL, associated necroptosis and their demarcation to other forms of regulated cell death in cancer will be needed for therapeutic exploitation of these pathways to the benefit of patients with cancer. The gene discussed is MLKL; the disease is cancer.